Astellas to Form Strategic Partnership with ClearPath to Build Vaccine Portfolio

News   Jan 07, 2014

 
Astellas to Form Strategic Partnership with ClearPath to Build Vaccine Portfolio
 
 
 
 

RELATED ARTICLES

U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast Milk

News

The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.

READ MORE

Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS Vaccine

News

The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.

READ MORE

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE